Hangzhou Tigermed Consulting Co Ltd 每股年股息为 0.7408,收益率为 0.00%。股息每 每年 支付,最近的除息日为 Jun 17, 2025。
股息收益率
年度股息
除息日
0.00%
$0.7408
Jun 17, 2025
支付频率
派息比率
每年
0.00%
股息历史
除息日
现金金额
记录日期
付款日期
Jun 17, 2025
$0.30
Jun 16, 2025
Jun 17, 2025
Jul 12, 2024
$0.568
Jul 11, 2024
Jul 12, 2024
Jul 7, 2023
$0.55
Jul 6, 2023
Jul 7, 2023
May 31, 2022
$0.50
May 30, 2022
May 31, 2022
Jun 1, 2021
$0.30
May 31, 2021
Jun 1, 2021
May 22, 2020
$0.278
May 21, 2020
May 22, 2020
股息图表
HNGZY 股息
HNGZY 股息增长率(同比)
关键数据
前收盘价
$4
开盘价
$4
当日区间
$4 - $4
52周范围
$4 - $4.2
交易量
612
平均成交量
0
每股收益(TTM)
0.15
股息收益率
--
市值
$3.4B
什么是 HANGZHOU TIGERMED CONSULTING CO?
Hangzhou Tigermed Consulting Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Hangzhou, Zhejiang and currently employs 10,185 full-time employees. The company went IPO on 2012-08-17. Hangzhou Tigermed Consulting Co Ltd is a China-based holding company engaged in providing clinical trial services for research and development of new drugs. The firm operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary. The firm conducts its businesses in the domestic and overseas markets.